ATE401903T1 - Verbessertes verfahren zur herstellung von ginkgoextrakten mit geringem gehalt an 4'-o- methylpyridoxin und/oder biflavonen - Google Patents

Verbessertes verfahren zur herstellung von ginkgoextrakten mit geringem gehalt an 4'-o- methylpyridoxin und/oder biflavonen

Info

Publication number
ATE401903T1
ATE401903T1 AT06742753T AT06742753T ATE401903T1 AT E401903 T1 ATE401903 T1 AT E401903T1 AT 06742753 T AT06742753 T AT 06742753T AT 06742753 T AT06742753 T AT 06742753T AT E401903 T1 ATE401903 T1 AT E401903T1
Authority
AT
Austria
Prior art keywords
methylpyridoxine
biflavones
low
improved method
ginkgo extracts
Prior art date
Application number
AT06742753T
Other languages
English (en)
Inventor
Clemens Erdelmeier
Hermann Hauer
Egon Koch
Friedrich Lang
Original Assignee
Schwabe Willmar Gmbh & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schwabe Willmar Gmbh & Co filed Critical Schwabe Willmar Gmbh & Co
Application granted granted Critical
Publication of ATE401903T1 publication Critical patent/ATE401903T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT06742753T 2005-05-03 2006-04-28 Verbessertes verfahren zur herstellung von ginkgoextrakten mit geringem gehalt an 4'-o- methylpyridoxin und/oder biflavonen ATE401903T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005020685 2005-05-03
DE102005061948A DE102005061948A1 (de) 2005-05-03 2005-12-23 Verbessertes Verfahren zur Herstellung von 4'-O-Methylpyridoxin- und/oder Biflavon-armen Ginkgoextrakten

Publications (1)

Publication Number Publication Date
ATE401903T1 true ATE401903T1 (de) 2008-08-15

Family

ID=36693938

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06742753T ATE401903T1 (de) 2005-05-03 2006-04-28 Verbessertes verfahren zur herstellung von ginkgoextrakten mit geringem gehalt an 4'-o- methylpyridoxin und/oder biflavonen

Country Status (26)

Country Link
US (2) US20060251746A1 (de)
EP (1) EP1868625B1 (de)
JP (2) JP4304230B2 (de)
KR (1) KR100933721B1 (de)
CN (2) CN104189025A (de)
AR (1) AR054270A1 (de)
AT (1) ATE401903T1 (de)
AU (1) AU2006243378B2 (de)
BR (1) BRPI0611093B1 (de)
CA (1) CA2606843C (de)
DE (2) DE102005061948A1 (de)
DK (1) DK1868625T3 (de)
DO (1) DOP2006000091A (de)
ES (1) ES2310408T3 (de)
JO (1) JO2523B1 (de)
MX (1) MX2007013398A (de)
MY (1) MY143650A (de)
NZ (1) NZ563818A (de)
PE (1) PE20061296A1 (de)
PL (1) PL1868625T3 (de)
PT (1) PT1868625E (de)
RU (1) RU2367459C2 (de)
SI (1) SI1868625T1 (de)
TW (1) TWI376230B (de)
UA (1) UA84519C2 (de)
WO (1) WO2006117169A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3446696A1 (de) 2007-12-21 2019-02-27 Dr. Willmar Schwabe GmbH & Co. KG Verwendung eines extraktes aus blättern von ginkgo biloba
EP2494979B1 (de) 2011-03-04 2019-03-27 Dr. Willmar Schwabe GmbH & Co. KG Verwendung von Extrakten aus Blättern von Ginkgo biloba zur Prävention und Therapie von Komplikationen nach operativer Arteriosklerose-Behandlung sowie von Folgeerscheinungen der Arteriosklerose
MX341428B (es) 2011-04-27 2016-08-18 Dr Willmar Schwabe Gmbh & Co Kg Tableta de liberacion controlada de extracto de ginkgo biloba y procedimiento para su obtencion.
DE102014202318B4 (de) * 2014-02-10 2016-10-06 Dr. Willmar Schwabe Gmbh & Co. Kg Verbessertes Verfahren zur Herstellung von Ginkgoextrakten
CN103919768B (zh) * 2014-03-30 2016-03-16 吴静 一种含有异银杏双黄酮和白果内酯的药物组合物及其制剂
CN107509997B (zh) * 2017-09-08 2021-02-26 南京林业大学 一种基于内源糖苷酶酶解结合树脂吸附脱除白果致毒成分的方法及其制备的产品和应用
CN107647407A (zh) * 2017-11-14 2018-02-02 宜昌东方昌绿茶业有限公司 一种从银杏茶中提取黄酮素的方法
CN113491721B (zh) * 2020-03-19 2022-05-31 江苏得乐康生物科技有限公司 一种脱除银杏叶提取物中银杏毒素的方法
CN115894424B (zh) * 2023-01-06 2023-05-12 中日友好医院(中日友好临床医学研究所) 新型双黄酮类化合物及其制备方法、药物组合物和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2627387B1 (fr) * 1988-02-24 1992-06-05 Fabre Sa Pierre Procede d'obtention d'un extrait de feuilles de ginkgo biloba
GB8822004D0 (en) * 1988-09-20 1988-10-19 Indena Spa New extracts of ginkgo biloba & their methods of preparation
DE3940091A1 (de) * 1989-12-04 1991-06-06 Schwabe Willmar Gmbh & Co Extrakt aus blaettern von ginkgo biloba, verfahren zu seiner herstellung und den extrakt enthaltende arzneimittel
JP3518882B2 (ja) 1993-11-12 2004-04-12 ダイセル化学工業株式会社 イチョウエキス及びその製造法
DE19756848C2 (de) * 1997-12-19 2003-01-16 Schwabe Willmar Gmbh & Co Extrakte aus Blättern von Ginkgo biloba mit vermindertem Gehalt an 4'-O-Methylpyridoxin und Biflavonen
US20040076691A1 (en) * 2002-01-16 2004-04-22 David Haines Anti-inflammatory formulations
CN1251675C (zh) * 2004-02-10 2006-04-19 张正生 一种注射用银杏达莫粉针剂及其制备方法
CN100451013C (zh) * 2004-04-21 2009-01-14 徐州技源天然保健品有限公司 一种从卷柏中提取穗花杉双黄酮提取物的生产工艺

Also Published As

Publication number Publication date
NZ563818A (en) 2009-11-27
BRPI0611093A2 (pt) 2010-08-10
US20080286391A1 (en) 2008-11-20
DE102005061948A1 (de) 2006-11-16
TW200716149A (en) 2007-05-01
US8642099B2 (en) 2014-02-04
EP1868625B1 (de) 2008-07-23
CA2606843A1 (en) 2006-11-09
JO2523B1 (en) 2010-03-17
ES2310408T3 (es) 2009-01-01
JP4304230B2 (ja) 2009-07-29
MX2007013398A (es) 2007-12-07
CN101175505A (zh) 2008-05-07
KR20070112271A (ko) 2007-11-22
CA2606843C (en) 2010-05-25
TWI376230B (en) 2012-11-11
RU2367459C2 (ru) 2009-09-20
JP2008540354A (ja) 2008-11-20
SI1868625T1 (sl) 2008-12-31
JP2009173663A (ja) 2009-08-06
UA84519C2 (ru) 2008-10-27
PT1868625E (pt) 2008-09-22
RU2007143632A (ru) 2009-06-10
US20060251746A1 (en) 2006-11-09
WO2006117169A1 (en) 2006-11-09
AU2006243378B2 (en) 2008-03-20
BRPI0611093B1 (pt) 2018-01-16
AR054270A1 (es) 2007-06-13
MY143650A (en) 2011-06-30
DOP2006000091A (es) 2007-01-31
PL1868625T3 (pl) 2009-01-30
PE20061296A1 (es) 2007-01-06
AU2006243378A1 (en) 2006-11-09
DE602006001949D1 (de) 2008-09-04
EP1868625A1 (de) 2007-12-26
CN104189025A (zh) 2014-12-10
KR100933721B1 (ko) 2009-12-24
DK1868625T3 (da) 2008-11-10

Similar Documents

Publication Publication Date Title
EP1877175A4 (de) Vorrichtung und verfahren zur herstellung von radiopharmazeutika
DE602006014546D1 (de) Verfahren und vorrichtung zur herstellung von turbinen- oder kompressorrädern
DE602004026045D1 (de) Verfahren zur herstellung von kugellagern
DE602004020476D1 (de) Verfahren zur herstellung von thermoplastischen vulkanisaten und thermoplastischen vulkanisaten
DE502004001634D1 (de) Gestängekonstruktion und Verfahren zur Herstellung einer solchen
DE602005010709D1 (de) Verfahren zur herstellung von pflanzenextrakten und heimtierfuttermitteln
EP2064364A4 (de) Verfahren und vorrichtung zur herstellung von kleinen strukturen
DE60326628D1 (de) Dorn und verfahren zur herstellung von stents
DE102004020497B8 (de) Verfahren zur Herstellung von Durchkontaktierungen und Halbleiterbauteil mit derartigen Durchkontaktierungen
DE602004008685D1 (de) Verbundwerkstoff und Verfahren zur Herstellung desselben
DE602004028894D1 (de) Sensor und Verfahren zur Herstellung desselben
EP1730318A4 (de) Zirconiumlegierungen mit verbesserter korrosionsbeständigkeit und verfahren zur herstellung von zirconiumlegierungen mit verbesserter korrosionsbeständigkeit
AT502301A3 (de) Röntgenanode und verfahren zur herstellung derselben
DE602006016199D1 (de) Nadellager mit einem Käfig und Verfahren zur Herstellung des Käfigs
ATE401903T1 (de) Verbessertes verfahren zur herstellung von ginkgoextrakten mit geringem gehalt an 4'-o- methylpyridoxin und/oder biflavonen
DE10242955B4 (de) Kunststoffaß und Verfahren zur Herstellung des Fasses
DE602005003061D1 (de) Mehrteilige Matratze oder Matratzendecke und Verfahren zur Herstellung derselben
DE50200467D1 (de) SPM-Sensor und Verfahren zur Herstellung desselben
DE602005010998D1 (de) Verfahren und einrichtung zur herstellung von metallfolien
ATE458743T1 (de) Zwischenprodukt und verfahren zur herstellung von an beta-anomeren angereicherten 2'-desoxy,2',2'- difluor-d-ribufuranosylnukleosiden
DE602006013572D1 (de) Resistzusammensetzung und Verfahren zur Herstellung von Mustern
ATE406992T1 (de) Verfahren und vorrichtung zur herstellung von kunststoffprofilen
ATE406372T1 (de) Verfahren zur herstellung von 3-o-geschützten morphinonen und 3-o-geschützten morphinondienolcarboxylaten
DE602004028364D1 (de) Verfahren zur herstellung von anorganischen kugeln
DE602005001366D1 (de) Verfahren zur Herstellung von Cycloalkanol und/oder Cycloalkanon

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1868625

Country of ref document: EP